{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:27:45Z","timestamp":1773235665153,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,11,12]],"date-time":"2011-11-12T00:00:00Z","timestamp":1321056000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2334-11-315","type":"journal-article","created":{"date-parts":[[2011,11,12]],"date-time":"2011-11-12T08:46:29Z","timestamp":1321087589000},"source":"Crossref","is-referenced-by-count":19,"title":["Rationale and design of a randomized controlled trial of directly observed hepatitis C treatment delivered in methadone clinics"],"prefix":"10.1186","volume":"11","author":[{"given":"Alain H","family":"Litwin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina M","family":"Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Hidalgo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia H","family":"Arnsten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,12]]},"reference":[{"key":"1646_CR1","first-page":"561","volume-title":"Hepatitis c treatment for injection drug users: a review of the available evidence: CID","author":"M Hellard","year":"2009","unstructured":"Hellard M, Sacks-Davis R, Gold J: Hepatitis c treatment for injection drug users: a review of the available evidence: CID. 2009, 49: 561-573."},{"key":"1646_CR2","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1097\/MEG.0b013e3281bcb8d8","volume":"19","author":"D Sylvestre","year":"2007","unstructured":"Sylvestre D, Clements B: Adherence to hepatitis C treatment in recovering heroin users maintained on methadone. Eur J Gastroenterol Hepatol. 2007, 19: 741-47. 10.1097\/MEG.0b013e3281bcb8d8.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1646_CR3","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1111\/j.1440-1746.2007.05032.x","volume":"22","author":"J Grebely","year":"2007","unstructured":"Grebely J, Raffa JD, Meagher C, et al: Directly observed therapy for the treatment of hepatitis C virus infection in current and former injection drug users. Journal of Gastroenterology and Hepatology. 2007, 22: 1519-1525. 10.1111\/j.1440-1746.2007.05032.x.","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"4","key":"1646_CR4","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1053\/gast.2002.35950","volume":"123","author":"JG McHutchison","year":"2002","unstructured":"McHutchison JG, Manns M, Patel K, et al: Adherence to combination therapy enhances sustained response in genotype 1-infected patients with chronic hepatitis C. Gastroenterology. 2002, 123 (4): 1061-1069. 10.1053\/gast.2002.35950.","journal-title":"Gastroenterology"},{"key":"1646_CR5","volume-title":"Drug and Alcohol Dependence","author":"KM Berg","year":"2010","unstructured":"Berg KM, Litwin AH, Li X, Heo M, Arnsten JH: Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: a randomized controlled trial. Drug and Alcohol Dependence. 2010"},{"key":"1646_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1300\/J069v15n01_07","volume":"15","author":"MN Gourevitch","year":"1996","unstructured":"Gourevitch MN, Wasserman W, Panero MS, et al: Successful adherence to observed prophylaxis and treatment of tuberculosis among drug users in a methadone program. Journal of Addictive Diseases. 1996, 15: 93-","journal-title":"Journal of Addictive Diseases"},{"key":"1646_CR7","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1053\/j.gastro.2004.01.014","volume":"126","author":"ML Shiffman","year":"2004","unstructured":"Shiffman ML, Di Bisceglie AM, Lindsay KL, et al: Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment. Gastroenterology. 2004, 126: 1015-1023. 10.1053\/j.gastro.2004.01.014.","journal-title":"Gastroenterology"},{"issue":"3","key":"1646_CR8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1053\/jhep.2003.50364","volume":"38","author":"GL Davis","year":"2003","unstructured":"Davis GL, Wong JB, McHutchison JG, et al: Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C. Hepatology. 2003, 38 (3): 645-652. 10.1053\/jhep.2003.50364.","journal-title":"Hepatology"},{"key":"1646_CR9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1365-2893.2006.00806.x","volume":"14","author":"B Ramos","year":"2007","unstructured":"Ramos B, Nunez M, Rendon A, et al: Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV\/HIV-coinfected patients. Journal of Viral Hepatitis. 2007, 14: 387-391. 10.1111\/j.1365-2893.2006.00806.x.","journal-title":"Journal of Viral Hepatitis"},{"key":"1646_CR10","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1111\/j.1572-0241.2008.02065.x","volume":"103","author":"H Bonkovsky","year":"2008","unstructured":"Bonkovsky H, Tice A, Yapp R, et al: Efficacy and safety of peginterferon alfa-2a\/ribavirin in methadone maintenance patients: randomized comparison of direct observed therapy and self-administration. Am J Gastroenterol. 2008, 103: 2757-2765. 10.1111\/j.1572-0241.2008.02065.x.","journal-title":"Am J Gastroenterol"},{"key":"1646_CR11","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jsat.2010.02.002","volume":"38","author":"M Waizmann","year":"2010","unstructured":"Waizmann M, Ackermann G: High rates of sustained virological response in hepatitis C virus-infected injection drug users receiving directly observed therapy with peginterferon alpha-2a (40KD) (PEGASYS) and once-daily ribavirin. J Substance Abuse Treatment. 2010, 38: 338-345. 10.1016\/j.jsat.2010.02.002.","journal-title":"J Substance Abuse Treatment"},{"key":"1646_CR12","doi-asserted-by":"publisher","first-page":"S339","DOI":"10.1086\/427450","volume":"40","author":"AH Litwin","year":"2005","unstructured":"Litwin AH, Soloway I, Gourevitch MN: Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities. Clinical Infectious Disease. 2005, 40: S339-S345. 10.1086\/427450.","journal-title":"Clinical Infectious Disease"},{"key":"1646_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jsat.2008.09.009","volume":"37","author":"AH Litwin","year":"2009","unstructured":"Litwin AH, Harris KA, Nahvi S, et al: Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program. Journal of Substance Abuse Treatment. 2009, 37: 32-40. 10.1016\/j.jsat.2008.09.009.","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"1646_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/ADM.0b013e3181add3de","volume":"4","author":"KA Harris Jr","year":"2010","unstructured":"Harris KA, Arnsten JH, Litwin AH: Successful integration of hepatitis C evaluation and treatment services with methadone maintenance. J Addict Med. 2010, 4 (1): 20-26. 10.1097\/ADM.0b013e3181add3de.","journal-title":"J Addict Med"},{"key":"1646_CR15","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/hep.22759","volume":"49","author":"M Ghany","year":"2009","unstructured":"Ghany M, Strader D, Thomas D, Seeff L: Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009, 49: 1335-1374. 10.1002\/hep.22759.","journal-title":"Hepatology"},{"issue":"9","key":"1646_CR16","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1001\/archinte.1987.00370090055011","volume":"147","author":"PF Renault","year":"1987","unstructured":"Renault PF, Hoofnagle JH, Park Y, Mullen KD, Peters M, Jones DB, Rustgi V, Jones EA: Psychiatric complications of long-term interferon alfa therapy. Arch Intern Med. 1987, 147 (9): 1577-1580. 10.1001\/archinte.147.9.1577.","journal-title":"Arch Intern Med"},{"issue":"4","key":"1646_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1055\/s-2008-1040523","volume":"9","author":"PF Renault","year":"1989","unstructured":"Renault PF, Hoofnagle JH: Side effects of alpha interferon. Semin Liver Dis. 1989, 9 (4): 273-277. 10.1055\/s-2008-1040523.","journal-title":"Semin Liver Dis"},{"issue":"5","key":"1646_CR18","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1176\/appi.psy.43.5.378","volume":"43","author":"RJ Fontana","year":"2002","unstructured":"Fontana RJ, Schwartz SM, Gebremariam A, Lok AS, Moyer CA: Emotional distress during interferon-alpha-2B and ribavirin treatment of chronic hepatitis C. Psychosomatics. 2002, 43 (5): 378-385. 10.1176\/appi.psy.43.5.378.","journal-title":"Psychosomatics"},{"issue":"3 Pt 1","key":"1646_CR19","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2466\/pr0.1996.79.3.1047","volume":"79","author":"SM Gavazzi","year":"1996","unstructured":"Gavazzi SM, Julian TW, McKenry PC: Utilization of the Brief Symptom inventory to discriminate between violent and nonviolent male relationship partners. Psychol Rep. 1996, 79 (3 Pt 1): 1047-1056.","journal-title":"Psychol Rep"},{"key":"1646_CR20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1176\/appi.psy.44.2.104","volume":"44","author":"E Dieperink","year":"2003","unstructured":"Dieperink E, Ho SB, Thuras P, Willenbring ML: A prospective study of neuropsychiatric symptoms associated with interferon alpha-2b and ribavirin therapy for patients with chronic hepatitis C. Psychosomatics. 2003, 44: 104-112. 10.1176\/appi.psy.44.2.104.","journal-title":"Psychosomatics"},{"issue":"18","key":"1646_CR21","first-page":"1737","volume":"282","author":"RL Spitzer","year":"1999","unstructured":"Spitzer RL, Kroenke K, Williams JB: Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999, 282 (18): 1737-1744.","journal-title":"Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA"},{"key":"1646_CR22","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.cct.2009.05.003","volume":"30","author":"KM Berg","year":"2009","unstructured":"Berg KM, Mouriz J, Li X, Duggan E, Goldberg U, Arnsten JH: Rationale, design, and sample characteristics of a randomized controlled trial of directly observed antiretroviral therapy delivered in methadone clinics. Contemporary clinical trials. 2009, 30: 481-489. 10.1016\/j.cct.2009.05.003.","journal-title":"Contemporary clinical trials"},{"issue":"3","key":"1646_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jsat.2005.06.002","volume":"29","author":"DL Sylvestre","year":"2005","unstructured":"Sylvestre DL, Litwin AH, Clements BJ, Gourevitch MN: The impact of barriers to hepatitis C virus treatment in recovering heroin users maintained on methadone. Journal of Substance Abuse Treatment. 2005, 29 (3): 159-165. 10.1016\/j.jsat.2005.06.002.","journal-title":"Journal of Substance Abuse Treatment"},{"key":"1646_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1365-2036.2009.04004.x","volume":"39","author":"JJ Weiss","year":"2009","unstructured":"Weiss JJ, Stivala A, Swan T, Fishbein D: Review article: adherence to medication for chronic hepatitis C - building on the model of human immunodeficiency virus antiretroviral adherence research. Alimentary Pharmacology and Therapeutics. 2009, 39: 14-27.","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"7","key":"1646_CR25","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1345\/aph.1K024","volume":"41","author":"SR Smith","year":"2007","unstructured":"Smith SR, Wahed AS, Kelley SS, et al: Assessing the validity of self-reported medication adherence in hepatitis C treatment. The Annals of Pharmacotherapy. 2007, 41 (7): 1116-1123. 10.1345\/aph.1K024.","journal-title":"The Annals of Pharmacotherapy"},{"key":"1646_CR26","first-page":"227","volume-title":"Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management: AIDS Behav","author":"JM Simoni","year":"2006","unstructured":"Simoni JM, Kurth AE, Pearson CR, et al: Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management: AIDS Behav. 2006, 10 (3): 227-245."},{"key":"1646_CR27","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1056\/NEJMoa0805062","volume":"360","author":"M Rodriguez-Torres","year":"2009","unstructured":"Rodriguez-Torres M, Jeffers LJ, Sheikh MY, et al: Peginterferon alfa-2a and ribavirin in Latino and non-Latino Whites with hepatitis C. N Engl J Med. 2009, 360: 257-267. 10.1056\/NEJMoa0805062.","journal-title":"N Engl J Med"},{"key":"1646_CR28","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1056\/NEJMoa032502","volume":"350","author":"AJ Muir","year":"2003","unstructured":"Muir AJ, Bornstein JD, Killenberg PG: Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-hispanic whites. N Engl J Med. 2003, 350: 2265-2271.","journal-title":"N Engl J Med"},{"key":"1646_CR29","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1002\/hep.20212","volume":"39","author":"L Jeffers","year":"2004","unstructured":"Jeffers L, Cassidy W, Howell CD, et al: Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1. Hepatology. 2004, 39: 1702-1708. 10.1002\/hep.20212.","journal-title":"Hepatology"},{"issue":"8","key":"1646_CR30","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1089\/apc.2006.0192","volume":"21","author":"GM Lucas","year":"2007","unstructured":"Lucas GM, Mullen BA, McCaul ME, et al: Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy. AIDS Patient Care STDS. 2007, 21 (8): 564-574. 10.1089\/apc.2006.0192.","journal-title":"AIDS Patient Care STDS"},{"issue":"25","key":"1646_CR31","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1056\/NEJMoa1012912","volume":"364","author":"IM Jacobson","year":"2011","unstructured":"Jacobson IM, McHutchison JG, Dusheiko G, et al: Telaprevir for previously untreated chronic hepatitis C infection. N Engl J Med. 2011, 364 (25): 2405-2416. 10.1056\/NEJMoa1012912.","journal-title":"N Engl J Med"},{"issue":"13","key":"1646_CR32","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1056\/NEJMoa1010494","volume":"364","author":"F Poordad","year":"2011","unstructured":"Poordad F, McCone J, Bacon BR, et al: Boceprevir for untreated chronic HCV genotype1 infection. N Engl J Med. 2011, 364 (13): 1195-1206. 10.1056\/NEJMoa1010494.","journal-title":"N Engl J Med"},{"issue":"3","key":"1646_CR33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/09540120050042891","volume":"12","author":"MA Chesney","year":"2000","unstructured":"Chesney MA, Ickovics JR, Chambers DB, et al: Self-reported adherence to antiretroviral medications among participants in HIV Clinical Trials: the AACTG adherence instruments. AIDS Care. 2000, 12 (3): 255-266. 10.1080\/09540120050042891.","journal-title":"AIDS Care"},{"issue":"3","key":"1646_CR34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3109\/00952998709001515","volume":"13","author":"L Handelsman","year":"1987","unstructured":"Handelsman L, Cochrane KJ, Aronson MJ, Ness R, Rubenstein KJ, Kanof PD: Two new rating scales for opiate withdrawal. Am J Drug Alcohol Abuse. 1987, 13 (3): 293-308. 10.3109\/00952998709001515.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"1646_CR35","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","volume":"9","author":"AT McLellan","year":"1992","unstructured":"McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M: The fifth edition of the addiction severity index. J Subst Abuse Treat. 1992, 9: 199-213. 10.1016\/0740-5472(92)90062-S.","journal-title":"J Subst Abuse Treat"},{"key":"1646_CR36","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","volume":"88","author":"JB Saunders","year":"1993","unstructured":"Saunders JB, Aasland OG, Babor TF, et al: Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption. II Addiction. 1993, 88: 791-804.","journal-title":"II Addiction"},{"key":"1646_CR37","unstructured":"Edlin B: Integrated vs. Separate Care for Hepatitis C, Substance Abuse, and HIV Prevention (NIDA R01DA029512; PI: B Edlin)."},{"issue":"2","key":"1646_CR38","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1037\/0022-3514.56.2.267","volume":"56","author":"CS Carver","year":"1989","unstructured":"Carver CS, Scheier MF, Wintraub JK: Assessing coping strategies: A theoretically based approach. Journal of Personality and Social Psychology. 1989, 56 (2): 267-283.","journal-title":"Journal of Personality and Social Psychology"},{"key":"1646_CR39","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"A Beck","year":"1961","unstructured":"Beck A, Ward C, Mendelson M: An Inventory for Measuring Depression. Archives of Psychiatry. 1961, 4: 561-567.","journal-title":"Archives of Psychiatry"},{"key":"1646_CR40","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1176\/appi.psy.44.2.104","volume":"44","author":"E Dieperink","year":"2003","unstructured":"Dieperink E, Ho SB, Thuras P, Willenbring ML: A prospective study of neuropsychiatric symptoms associated with interferon alpha-2b and ribavirin therapy for patients with chronic hepatitis C. Psychosomatics. 2003, 44: 104-112. 10.1176\/appi.psy.44.2.104.","journal-title":"Psychosomatics"},{"issue":"9","key":"1646_CR41","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB: The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001, 16 (9): 606-613. 10.1046\/j.1525-1497.2001.016009606.x.","journal-title":"J Gen Intern Med"},{"key":"1646_CR42","volume-title":"The Brief Symptom Inventory (BSI): administration, scoring and procedure manual - 1","author":"LR Derogatis","year":"1982","unstructured":"Derogatis LR, Spencer PM: The Brief Symptom Inventory (BSI): administration, scoring and procedure manual - 1. 1982, Baltimore, MD: John Wiley"},{"issue":"5","key":"1646_CR43","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1176\/appi.psy.43.5.378","volume":"43","author":"RJ Fontana","year":"2002","unstructured":"Fontana RJ, Schwartz SM, Gebremariam A, Lok AS, Moyer CA: Emotional distress during interferon-alpha-2B and ribavirin treatment of chronic hepatitis C. Psychosomatics. 2002, 43 (5): 378-385. 10.1176\/appi.psy.43.5.378.","journal-title":"Psychosomatics"},{"issue":"3 Pt 1","key":"1646_CR44","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2466\/pr0.1996.79.3.1047","volume":"79","author":"SM Gavazzi","year":"1996","unstructured":"Gavazzi SM, Julian TW, McKenry PC: Utilization of the Brief Symptom inventory to discriminate between violent and nonviolent male relationship partners. Psychol Rep. 1996, 79 (3 Pt 1): 1047-1056.","journal-title":"Psychol Rep"},{"key":"1646_CR45","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1207\/s15327752jpa6601_2","volume":"66","author":"D Russell","year":"1996","unstructured":"Russell D: The UCLA Loneliness Scale (Version 3): reliability, validity, and factor structure. Journal of Personality Assessment. 1996, 66: 20-40. 10.1207\/s15327752jpa6601_2.","journal-title":"Journal of Personality Assessment"},{"issue":"6","key":"1646_CR46","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/0277-9536(91)90150-B","volume":"32","author":"CD Sherbourne","year":"1991","unstructured":"Sherbourne CD, Stewart AL: The MOS Social Support Survey. Soc Sci Med. 1991, 32 (6): 705-714. 10.1016\/0277-9536(91)90150-B.","journal-title":"Soc Sci Med"},{"key":"1646_CR47","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1177\/07399863870092005","volume":"9","author":"G Marin","year":"1987","unstructured":"Marin G, Sabogal F, VanOss Marin B, Otero-Sabogal F, Perez-Stable EJ: Development of a short acculturation scale for Hispanics. Hispanic J Behavioral Sciences. 1987, 9: 183-205. 10.1177\/07399863870092005.","journal-title":"Hispanic J Behavioral Sciences"},{"issue":"5","key":"1646_CR48","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF02506900","volume":"22","author":"DE Cortes","year":"1994","unstructured":"Cortes DE, Rogler LH, Malgady RG: Biculturality among Puerto Rican adults in the United States. Am J Community Psychology. 1994, 22 (5): 707-721. 10.1007\/BF02506900.","journal-title":"Am J Community Psychology"},{"issue":"4","key":"1646_CR49","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1089\/108729100317795","volume":"14","author":"S Bakken","year":"2000","unstructured":"Bakken S, Holzemer WL, Brown MA, Powell-Cope GM, Turner JG, Inouye J, et al: Relationships between perception of engagement with health care provider and demographic characteristics, health status, and adherence to therapeutic regimen in persons with HIV\/AIDS. AIDS Patient Care STDS. 2000, 14 (4): 189-197. 10.1089\/108729100317795.","journal-title":"AIDS Patient Care STDS"},{"issue":"1","key":"1646_CR50","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1076\/clin.12.1.43.1726","volume":"12","author":"RHB Benedict","year":"1998","unstructured":"Benedict RHB, Schretien D, Groninger L, Brandt J: Hopkins Verbal Learning Test - revised: normative data and analysis of inter-form and test-retest reliability. The Clinical Neuropsychologist. 1998, 12 (1): 43-55. 10.1076\/clin.12.1.43.1726.","journal-title":"The Clinical Neuropsychologist"},{"key":"1646_CR51","volume-title":"The Wide Range Achievement Test: Manual","author":"GS Wilkinson","year":"1993","unstructured":"Wilkinson GS: The Wide Range Achievement Test: Manual. 1993, Wilmington, DE: Wide Range, 3","edition":"3"},{"key":"1646_CR52","unstructured":"Weschler Abbreviated Scale of Intelligence. 1997, (WAIS-3\u00ae). San Antonio, TX: Harcourt Assessment, 3"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-11-315\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-315.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-315","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-315.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T04:33:24Z","timestamp":1548218004000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-11-315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,12]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1646"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-11-315","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,12]]},"article-number":"315"}}